A new analgesia regimen after (adeno) tonsillectomy in children: a pilot study

Objective The objective was to ascertain the efficacy of a new analgesic regimen introduced in children undergoing (adeno)tonsillectomy in view of the ban on codeine use in children <12 years by the European Medicines Agency (EMA) and UK Medicines and Healthcare Products Regulatory Agency (MHRA)....

Full description

Saved in:
Bibliographic Details
Published inClinical otolaryngology Vol. 41; no. 6; pp. 660 - 665
Main Authors Syed, M.I., Magos, T.A., Singh, J., Montague, M.L.
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.12.2016
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective The objective was to ascertain the efficacy of a new analgesic regimen introduced in children undergoing (adeno)tonsillectomy in view of the ban on codeine use in children <12 years by the European Medicines Agency (EMA) and UK Medicines and Healthcare Products Regulatory Agency (MHRA). Design Prospective pilot study at a paediatric tertiary referral centre. Materials and methods A total of 176 children undergoing (adeno) tonsillectomy over a 5‐month period (Sept 2013‐Jan 2014) were included in the study. Data were prospectively collected on analgesia used peri‐operatively and patients were discharged on regular paracetamol and ibuprofen for 7 days and three doses of oral morphine sulphate solution to be used on days 3, 4 and 5. Pain scores were recorded on days 1–10 post‐operatively using the Wong Baker Faces Pain Rating scale. Results The pain scores were significantly better (P‐value < 0.0001) in children who were compliant with morphine (n = 93) than those who were not (n = 32). We also found that children who were compliant with morphine were less likely to seek help out of hours (P‐value < 0.001). Conclusions Oral morphine sulphate solution provides a reasonable alternative to codeine, albeit one should bear in mind that parental concerns and adverse effects of the drug were seen in a minority of patients (n = 11) and anaesthetists were reluctant to prescribe the drug in cases of severe OSA or associated central apnoeas (n = 7).
Bibliography:ArticleID:COA12579
istex:281CA80A3F702DB2045AFAAFAE19E50B888391E0
ark:/67375/WNG-L7BLTQ5C-L
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:1749-4478
1749-4486
DOI:10.1111/coa.12579